| scholarly article | Q13442814 |
| P50 | author | Jenny L. Wiley | Q42407062 |
| Brian F Thomas | Q60314995 | ||
| P2093 | author name string | Billy R Martin | |
| Anu Mahadevan | |||
| Raj K Razdan | |||
| Sucharita Roy | |||
| Caryl Bourne | |||
| P2860 | cites work | 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor | Q24620096 |
| (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability | Q28244400 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| Determination and characterization of a cannabinoid receptor in rat brain | Q29618888 | ||
| Discovery and characterization of endogenous cannabinoids | Q33720094 | ||
| Pharmacology of cannabinoid receptor ligands. | Q33724151 | ||
| Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids | Q33724175 | ||
| SR141716A, a potent and selective antagonist of the brain cannabinoid receptor | Q34332716 | ||
| Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand | Q34404955 | ||
| Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations. | Q34410764 | ||
| Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
| SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. | Q34455195 | ||
| Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol | Q34476479 | ||
| Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor | Q34647833 | ||
| Pharmacological actions of cannabinoids. | Q36441175 | ||
| Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. | Q39502390 | ||
| Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists | Q44863367 | ||
| Pharmacological and behavioral evaluation of alkylated anandamide analogs | Q45084216 | ||
| Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs | Q45084407 | ||
| The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice | Q45087565 | ||
| Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC. | Q45090998 | ||
| Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol | Q45103517 | ||
| Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys | Q45108581 | ||
| Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase | Q48251232 | ||
| Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability | Q48314928 | ||
| Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent | Q48332786 | ||
| Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide | Q48600066 | ||
| Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. | Q52060269 | ||
| Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore. | Q54467581 | ||
| Potent Anandamide Analogs: The Effect of Changing the Length and Branching of the End Pentyl Chain | Q62066443 | ||
| Preparation of a cis-isoprostane synthon | Q74331184 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anandamide | Q410228 |
| cannabinoids | Q422936 | ||
| P304 | page(s) | 7850-7864 | |
| P577 | publication date | 2007-08-25 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
| P1476 | title | Novel, potent THC/anandamide (hybrid) analogs | |
| P478 | volume | 15 |
| Q37206915 | Design and synthesis of (13S)-methyl-substituted arachidonic acid analogues: templates for novel endocannabinoids |
| Q24569817 | N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase |
Search more.